The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

25 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization.EBI
Shandong University
Steric structure-activity relationship of cyproheptadine derivatives as inhibitors of histone methyltransferase Set7/9.EBI
Tokyo Medical and Dental University (Tmdu)
Identification of Cyproheptadine as an Inhibitor of SET Domain Containing Lysine Methyltransferase 7/9 (Set7/9) That Regulates Estrogen-Dependent Transcription.EBI
Riken
Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual Screening.EBI
Shanghai University
Selective inhibitors of protein methyltransferases.EBI
Icahn School of Medicine At Mount Sinai
SAH derived potent and selective EZH2 inhibitors.EBI
Pfizer
Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.EBI
University of North Carolina At Chapel Hill
Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screening.EBI
Chinese Academy of Sciences
Using 'biased-privileged' scaffolds to identify lysine methyltransferase inhibitors.EBI
Rockefeller University
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2.EBI
TBA
Toward the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases.EBI
University Park
Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines.EBI
University of North Carolina At Chapel Hill
Novel 3,5-bis(bromohydroxybenzylidene)piperidin-4-ones as coactivator-associated arginine methyltransferase 1 inhibitors: enzyme selectivity and cellular activity.EBI
The University of Texas M.D. Anderson Cancer Center
Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1.EBI
Albert-Ludwigs-University of Freiburg
Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines.EBI
University of North Carolina At Chapel Hill
1,2-Diamines as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1).EBI
Methylgene
Fascinating Transformation of SAM-Competitive Protein Methyltransferase Inhibitors from Nucleoside Analogues to Non-Nucleoside Analogues.EBI
Csir-Indian Institute of Chemical Biology
Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library.EBI
University of Michigan Medical School
Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors.EBI
University of Chinese Academy of Sciences
Computational discovery and biological evaluation of novel inhibitors targeting histone-lysine N-methyltransferase SET7.EBI
China Pharmaceutical University
New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms.EBI
University College London
Histone methyl transferases: A class of epigenetic opportunities to counter uncontrolled cell proliferation.EBI
Punjabi University
Discovery of Bisubstrate Inhibitors for Protein N-Terminal Methyltransferase 1.EBI
Purdue University
Novel Propargyl-Linked Bisubstrate Analogues as Tight-Binding Inhibitors for Nicotinamide EBI
TBA